Carbon-based nanomaterials accelerate arteriolar thrombus formation in the murine microcirculation independently of their shape

Journal of Applied Toxicology

Volumn 34, Issue 11, 2014, Pages 1167-1176

  Holzer, Martin ^a   Bihari, Peter ^a   Praetner, Marc ^a   Uhl, Bernd ^a   Reichel, Christoph ^a   Fent, Janos ^b   Vippola, Minnamari ^c,d   Lakatos, Susan ^b   Krombach, Fritz ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Medical Centre   (Hungary)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Carbon black; Carbon nanotubes; in vivo microscopy; Inflammation; Leukocytes; Microcirculation; Nanoparticles; Platelets; Thrombosis

Indexed keywords

CARBON NANOPARTICLE; CD11B ANTIGEN; CD18 ANTIGEN; FIBER SHAPED SINGLE WALLED CARBON NANOTUBE; GLYCOPROTEIN P 15095; PADGEM PROTEIN; SPHERICAL ULTRAFINE CARBON BLACK; UNCLASSIFIED DRUG; CARBON NANOTUBE; SOOT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; LEUKOCYTE; MALE; MICROCIRCULATION; NONHUMAN; NORMAL HUMAN; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ACTIVATION; THROMBOCYTOPOIESIS; THROMBOGENICITY; THROMBOSIS; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; ARTERIOLE; C57BL MOUSE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE; PATHOLOGY; SOOT; THROMBOCYTE; TOXICITY;

ANIMALS; ARTERIOLES; BLOOD PLATELETS; ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICROCIRCULATION; MICROSCOPY, ELECTRON, SCANNING; NANOTUBES, CARBON; P-SELECTIN; SOOT; THROMBOSIS;

EID: 84907878199     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2996     Document Type: Article

References (49)

1. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61: 428-437.
2. Al Faraj A, Fauvelle F, Luciani N, Lacroix G, Levy M, Cremillieux Y, Canet-Soulas E. 2011. In vivo biodistribution and biological impact of injected carbon nanotubes using magnetic resonance techniques. Int. J. Nanomedicine 6: 351-361.
3. Baez S. 1973. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc. Res. 5: 384-394.
4. Bai Y, Zhang Y, Zhang J, Mu Q, Zhang W, Butch ER, Snyder SE, Yan B. 2010. Repeated administrations of carbon nanotubes in male mice cause reversible testis damage without affecting fertility. Nat. Nanotechnol. 5: 683-689.
5. Bihari P, Holzer M, Praetner M, Fent J, Lerchenberger M, Reichel CA, Rehberg M, Lakatos S, Krombach F. 2010. Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation. Toxicology 269: 148-154.
6. Bihari P, Fent J, Hamar J, Furesz J, Lakatos S. 2008a. An easy-to-use practical method to measure coincidence in the flow cytometer--the case of platelet-granulocyte complex determination. J. Biochem. Biophys. Methods 70: 1080-1085.
7. Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA, Coester C, Tuomi T, Rehberg M, Krombach F. 2008b. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part. Fibre Toxicol. 5: 14.
8. Campagnolo L, Massimiani M, Palmieri G, Bernardini R, Sacchetti C, Bergamaschi A, Vecchione L, Magrini A, Bottini M, Pietroiusti A. 2013. Biodistribution and toxicity of pegylated single wall carbon nanotubes in pregnant mice. Part. Fibre Toxicol. 10: 21.
9. Cedervall T, Lynch I, Foy M, Berggard T, Donnelly SC, Cagney G, Linse S, Dawson KA. 2007. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. Engl. 46: 5754-5756.
10. Clift MJ, Bhattacharjee S, Brown DM, Stone V. 2010. The effects of serum on the toxicity of manufactured nanoparticles. Toxicol. Lett. 198: 358-365.
11. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, Jacobs JM, Addleman SR, Kaysen GA, Moudgil BM, Weber TJ. 2007. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol. Sci. 100: 303-315.
12. Erdely A, Hulderman T, Salmen R, Liston A, Zeidler-Erdely PC, Schwegler-Berry D, Castranova V, Koyama S, Kim YA, Endo M, Simeonova PP. 2009. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett. 9: 36-43.
13. Guidetti GF, Consonni A, Cipolla L, Mustarelli P, Balduini C, Torti M. 2012. Nanoparticles induce platelet activation in vitro through stimulation of canonical signalling pathways. Nanomedicine 8: 1329-1336.
14. Kendall M, Ding P, Kendall K. 2011. Particle and nanoparticle interactions with fibrinogen: the importance of aggregation in nanotoxicology. Nanotoxicology 5: 55-65.
15. Khandoga A, Stampfl A, Takenaka S, Schulz H, Radykewicz R, Kreyling W, Krombach F. 2004. Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation 109: 1320-1325.
16. Khandoga A, Stoeger T, Khandoga AG, Bihari P, Karg E, Ettehadieh D, Lakatos S, Fent J, Schulz H, Krombach F. 2010. Platelet adhesion and fibrinogen deposition in murine microvessels upon inhalation of nanosized carbon particles. J. Thromb. Haemost. 8: 1632-1640.
17. Krug HF, Wick P. 2011. Nanotoxicology: An Interdisciplinary Challenge. Angew. Chem. Int. Ed. Engl. 50: 1260-1278.
18. Kunkel EJ, Jung U, Bullard DC, Norman KE, Wolitzky BA, Vestweber D, Beaudet AL, Ley K. 1996. Absence of trauma-induced leukocyte rolling in mice deficient in both P-selectin and intercellular adhesion molecule 1. J. Exp. Med. 183: 57-65.
19. Lacerda SH, Semberova J, Holada K, Simakova O, Hudson SD, Simak J. 2011. Carbon nanotubes activate store-operated calcium entry in human blood platelets. ACS Nano 5: 5808-5813.
20. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7: 678-689.
21. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U. S. A. 105: 14265-14270.
22. Lynch I, Dawson KA. 2008. Protein-nanoparticle interactions. Nano Today 3: 40-47.
23. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB. 2006. Safe handling of nanotechnology. Nature 444: 267-269.
24. Maynard AD, Warheit DB, Philbert MA. 2011. The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol. Sci. 120 (Suppl 1): S109-129.
25. Mempel TR, Moser C, Hutter J, Kuebler WM, Krombach F. 2003. Visualization of leukocyte transendothelial and interstitial migration using reflected light oblique transillumination in intravital video microscopy. J. Vasc. Res. 40: 435-441.
26. Meng J, Song L, Xu H, Kong H, Wang C, Guo X, Xie S. 2005. Effects of single-walled carbon nanotubes on the functions of plasma proteins and potentials in vascular prostheses. Nanomedicine 1: 136-142.
27. Mercer RR, Scabilloni JF, Hubbs AF, Wang L, Battelli LA, McKinney W, Castranova V, Porter DW. 2013. Extrapulmonary transport of MWCNT following inhalation exposure. Part. Fibre Toxicol. 10: 38.
28. Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311: 622-627.
29. Nemmar A, Hoylaerts MF, Hoet PH, Dinsdale D, Smith T, Xu H, Vermylen J, Nemery B. 2002. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am. J. Respir. Crit. Care Med. 166: 998-1004.
30. Nemmar A, Hoet PH, Vandervoort P, Dinsdale D, Nemery B, Hoylaerts MF. 2007. Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: role of P-selectin. J. Thromb. Haemost. 5: 1217-1226.
31. Oberdorster G, Oberdorster E, Oberdorster J. 2005a. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113: 823-839.
32. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. 2005b. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2: 8.
33. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3: 423-428.
34. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW. 2005. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 146: 882-893.
35. Rumbaut RE, Slaff DW, Burns AR. 2005. Microvascular thrombosis models in venules and arterioles in vivo. Microcirculation 12: 259-274.
36. Semberova J, De Paoli Lacerda SH, Simakova O, Holada K, Gelderman MP, Simak J. 2009. Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. Nano Lett. 9: 3312-3317.
37. Shi D, Bedford NM, Cho HS. 2011. Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics. Small 7: 2549-2567.
38. Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K. 2006. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. U. S. A. 103: 3357-3362.
39. Song L, Meng J, Zhong J, Liu L, Dou X, Liu D, Zhao X, Luo S, Zhang Z, Xiang Y, Xu H, Zhou W, Wu Z, Xie S. 2006. Human fibrinogen adsorption onto single-walled carbon nanotube films. Colloids Surf. B Biointerfaces 49: 66-70.
40. Tang S, Tang Y, Zhong L, Murat K, Asan G, Yu J, Jian R, Wang C, Zhou P. 2012. Short- and long-term toxicities of multi-walled carbon nanotubes in vivo and in vitro. J. Appl. Toxicol. 32: 900-912.
41. Tangelder GJ, Slaaf DW, Muijtjens AM, Arts T, oude Egbrink MG, Reneman RS. 1986. Velocity profiles of blood platelets and red blood cells flowing in arterioles of the rabbit mesentery. Circ. Res. 59: 505-514.
42. Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, Schlenk F, Fischer D, Kiouptsi K, Reinhardt C, Landfester K, Schild H, Maskos M, Knauer SK, Stauber RH. 2013. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 8: 772-781.
43. Terrones M, Terrones H. 2003. The carbon nanocosmos: novel materials for the twenty-first century. Philos. Transact. A Math. Phys. Eng. Sci. 361: 2789-2806.
44. Vippola M, Bard D, Sarlin E, Tuomi T, Tossavainen A. 2009. Nanoatlas of selected engineered nanoparticles. Finnish Institute of Occupational Health: Helsinki.
45. Wagner DD, Burger PC. 2003. Platelets in inflammation and thrombosis. Arterioscler. Thromb. Vasc. Biol. 23: 2131-2137.
46. Wang X, Podila R, Shannahan JH, Rao AM, Brown JM. 2013. Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis. Int. J. Nanomedicine 8: 1733-1748.
47. Yang ST, Wang X, Jia G, Gu Y, Wang T, Nie H, Ge C, Wang H, Liu Y. 2008. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. Toxicol. Lett. 181: 182-189.
48. Zanardo RC, Bonder CS, Hwang JM, Andonegui G, Liu L, Vestweber D, Zbytnuik L, Kubes P. 2004. A down-regulatable E-selectin ligand is functionally important for PSGL-1-independent leukocyte-endothelial cell interactions. Blood 104: 3766-3773.
49. Zarbock A, Polanowska-Grabowska RK, Ley K. 2007. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 21: 99-111.